Authors:
Saleem, A
Harte, RJ
Matthews, JC
Osman, S
Brady, F
Luthra, SK
Brown, GD
Bleehen, N
Conners, T
Jones, T
Price, PM
Aboagye, EO
Citation: A. Saleem et al., Pharmacokinetic evaluation of N-[2(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography, J CL ONCOL, 19(5), 2001, pp. 1421-1429
Authors:
Thomas, HD
Lind, MJ
Ford, J
Bleehen, N
Calvert, AH
Boddy, AV
Citation: Hd. Thomas et al., Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours, CANC CHEMOT, 45(4), 2000, pp. 284-290
Authors:
Chataway, J
Stenning, S
Bleehen, N
Grant, R
Citation: J. Chataway et al., Use of different outcome measures in randomised studies of malignant glioma can significantly alter the interpretation of time to progression: Reanalysis of the MRC BR2 study, J NEURO-ONC, 43(1), 1999, pp. 87-92